IT1219906B - Impieghi in terapeutica degli agonisti dei recettori dopaminergici - Google Patents

Impieghi in terapeutica degli agonisti dei recettori dopaminergici

Info

Publication number
IT1219906B
IT1219906B IT47814/88A IT4781488A IT1219906B IT 1219906 B IT1219906 B IT 1219906B IT 47814/88 A IT47814/88 A IT 47814/88A IT 4781488 A IT4781488 A IT 4781488A IT 1219906 B IT1219906 B IT 1219906B
Authority
IT
Italy
Prior art keywords
receptor agonists
therapeutic use
dopaminergic receptor
dopaminergic
therapeutic
Prior art date
Application number
IT47814/88A
Other languages
English (en)
Italian (it)
Other versions
IT8847814A0 (it
Inventor
Rudolf Markstein
Jose Palacios
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878708626A external-priority patent/GB8708626D0/en
Priority claimed from GB878708898A external-priority patent/GB8708898D0/en
Priority claimed from GB878710062A external-priority patent/GB8710062D0/en
Priority claimed from GB878720366A external-priority patent/GB8720366D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8847814A0 publication Critical patent/IT8847814A0/it
Application granted granted Critical
Publication of IT1219906B publication Critical patent/IT1219906B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IT47814/88A 1987-04-10 1988-04-05 Impieghi in terapeutica degli agonisti dei recettori dopaminergici IT1219906B (it)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB878708626A GB8708626D0 (en) 1987-04-10 1987-04-10 Indolophenanthridines
GB878708898A GB8708898D0 (en) 1987-04-14 1987-04-14 Indolophenanthridines
GB878710062A GB8710062D0 (en) 1987-04-28 1987-04-28 Indolophenanthridines
GB878720366A GB8720366D0 (en) 1987-08-28 1987-08-28 Dopamine d1 receptor agonists

Publications (2)

Publication Number Publication Date
IT8847814A0 IT8847814A0 (it) 1988-04-05
IT1219906B true IT1219906B (it) 1990-05-24

Family

ID=27449909

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47814/88A IT1219906B (it) 1987-04-10 1988-04-05 Impieghi in terapeutica degli agonisti dei recettori dopaminergici

Country Status (11)

Country Link
US (1) US4855306A ( )
JP (1) JPS63258819A ( )
KR (1) KR880012227A ( )
AU (1) AU1440088A ( )
DE (1) DE3811274A1 ( )
DK (1) DK193588A ( )
FR (1) FR2613623A1 ( )
GB (1) GB2205495A ( )
IT (1) IT1219906B ( )
NL (1) NL8800823A ( )
SE (1) SE8801275A0 ( )

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001514663A (ja) * 1997-03-12 2001-09-11 エスモンド，ロバート ダブリュー． アルツハイマー病を処置または予防するための方法
US20040058873A1 (en) * 1998-03-12 2004-03-25 Esmond Robert W. Method for treating or preventing Alzheimer's disease
US6362371B1 (en) * 1998-06-08 2002-03-26 Advanced Medicine, Inc. β2- adrenergic receptor agonists
DE10148233A1 (de) * 2001-09-28 2003-04-10 Boehringer Ingelheim Pharma Verbindungen zur Reduzierung übermäßiger Nahrungsaufnahme
US20050215552A1 (en) * 2002-05-17 2005-09-29 Gadde Kishore M Method for treating obesity
JP4545584B2 (ja) * 2002-05-17 2010-09-15 デューク ユニバーシティ 肥満を治療するための方法
DE10312809A1 (de) * 2003-03-21 2004-09-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pramipexol zur Reduzierung übermäßiger Nahrungsaufnahme bei Kindern
US20040266794A1 (en) * 2003-03-21 2004-12-30 Boehringer Ingelheim International Gmbh Pramipexole for the reduction of excessive food intake for children
PT2316456T (pt) * 2003-04-29 2017-09-05 Orexigen Therapeutics Inc Composições para afetar a perda de peso compreendendo naltrexona e bupropion
WO2004103262A2 (en) * 2003-05-22 2004-12-02 Yeda Research And Development Co. Ltd. Dopamine and agonists and antagonists thereof for modulation of suppressive activity of cd4+cd25+ regulatory t cells
BRPI0506829A (pt) * 2004-01-13 2007-05-29 Univ Duke composições de anticonvulsivo e droga antipsicótica e métodos para sua utilização para afetar perda de peso
US7713959B2 (en) * 2004-01-13 2010-05-11 Duke University Compositions of an anticonvulsant and mirtazapine to prevent weight gain
CA2565154A1 (en) * 2004-05-03 2005-11-24 Duke University Compositions for affecting weight loss
US20080306019A1 (en) * 2005-05-03 2008-12-11 Booze Rosemarie M Dopamine Receptor Agonists in the Treatment and Prevention of Hiv-Induced Dementia
DK2135603T3 (da) 2005-11-22 2013-03-25 Orexigen Therapeutics Inc Sammensætninger og fremgangsmåder til øgning af insulinsensitivitet
US8916195B2 (en) 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
AU2007319472B2 (en) 2006-11-09 2013-01-17 Nalpropion Pharmaceuticals Llc Methods Of Administering Weight Loss Medications
CN101588795A (zh) 2006-11-09 2009-11-25 奥雷西根治疗公司 包含中间快速溶解层的分层药物制剂
US20110144145A1 (en) 2008-05-30 2011-06-16 Orexigen Therapeutics, Inc. Methods for treating visceral fat conditions
CA2750903C (en) * 2009-08-27 2015-08-11 Daikin Industries, Ltd. Processing additive, molding composition, masterbatch of processing additive and molding article
AU2011203867B2 (en) 2010-01-11 2015-12-03 Nalpropion Pharmaceuticals Llc Methods of providing weight loss therapy in patients with major depression
EP2858640B1 (en) 2012-06-06 2020-03-25 Nalpropion Pharmaceuticals LLC Composition for use in a method of treating overweight and obesity in patients with high cardiovascular risk

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3402392A1 (de) * 1984-01-25 1985-08-01 Sandoz-Patent-GmbH, 7850 Lörrach Neue ergolinderivate, deren herstellung und deren verwendung

Also Published As

Publication number Publication date
SE8801275L (sv) 1988-10-19
US4855306A (en) 1989-08-08
KR880012227A (ko) 1988-11-26
JPS63258819A (ja) 1988-10-26
NL8800823A (nl) 1988-11-01
FR2613623A1 (fr) 1988-10-14
GB2205495A (en) 1988-12-14
DK193588A (da) 1988-10-11
AU1440088A (en) 1988-10-13
IT8847814A0 (it) 1988-04-05
GB8808125D0 (en) 1988-05-11
DE3811274A1 (de) 1988-10-27
SE8801275D0 (sv) 1988-04-08
DK193588D0 (da) 1988-04-08
SE8801275A0 (sv) 1988-10-19

Similar Documents

Publication Publication Date Title
IT1219906B (it) Impieghi in terapeutica degli agonisti dei recettori dopaminergici
IT1218150B (it) Impiego in terapeutica degli antago nisti dei recettori serotoninergici 5ht3
NZ228564A (en) Corticosteroid-containing skin care composition for use as moisturiser: preparation thereof
IT8867534A0 (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
IT8868118A0 (it) Composizione e procedimento per il trattamento e la cura dei capelli
FI92137B (fi) Ihon lämpötilan mittauslaite perifeerisen verenkierron häiriöiden määrittämiseksi
IT1157007B (it) Miscela fibrosa terapeutica di cellulosa e carbossimetilcellulosa ed impiego di tale miscela per il controllo della defecazione e dell'appetito in soggetti umani
KR890008742U (ko) 리클라이닝장치의 부착구조
IT8647977A0 (it) Impiego in terapeutica degli agonisti dopaminergici
ATA74788A (de) Schwenkarmvorrichtung
DK139188A (da) Superledende legeme samt apparat indeholdende dette
IT8847906A0 (it) Impiego in terapeutica degli agonisti dei ricettori della dopamina
IT8249067A0 (it) L'impiego in terapeutica dei derivati della diidropiridina
DK415087D0 (da) Terapeutiske midler indeholdende benzhydrylthiomethanderivater
EP0417637A3 (en) Use of dopamine autoreceptor agonists in the treatment of drug dependency
DE3855473D1 (de) Hyperthermiegerät
KR890004889U (ko) 연사기용 실린다의 핀 출몰장치
ATA215787A (de) Geraet zur koerperpflege
IT8619249A0 (it) Kit per la determinazione dell'attivita' proliferativa nei tumori umani.
ZA882478B (en) New uses of dopamine receptor agonists
ZA893145B (en) Therapeutic use of serotonin antagonists
KR880015616U (ko) 스폰지 어께패드 제조장치의 나이프
KR870018755U (ko) 열량계용 미터바디
ZA903015B (en) Therapeutic use of 5-ht3 receptor antagonists
KR880015720U (ko) 괘도걸이 겸용 흑판걸이